Cardiac metabolism in heart failure: implications beyond ATP production.
about
Rescue of Heart Failure by Mitochondrial RecoveryPivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved IssuesThe protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stressMitoconfusion: noncanonical functioning of dynamism factors in static mitochondria of the heartPresent and future pharmacotherapeutic agents in heart failure: an evolving paradigmBiallelic PPA2 Mutations Cause Sudden Unexpected Cardiac Arrest in InfancyMitochondria and oxidative stress in heart agingMonoamine Oxidases as Potential Contributors to Oxidative Stress in Diabetes: Time for a Study in Patients Undergoing Heart SurgeryTargeting mitochondrial dysfunction in the treatment of heart failure.Cardioprotective effects of dietary lipids evident in the time-dependent alterations of cardiac function and gene expression following myocardial infarction.Loss of dihydrolipoyl succinyltransferase (DLST) leads to reduced resting heart rate in the zebrafish.Titin-truncating variants affect heart function in disease cohorts and the general population.Comprehensive metabolic modeling of multiple 13C-isotopomer data sets to study metabolism in perfused working hearts.Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation.Inhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injurySevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signalingMitochondrial Ca(2+) uptake by the voltage-dependent anion channel 2 regulates cardiac rhythmicity.Application of time-resolved autofluorescence to label-free in vivo optical mapping of changes in tissue matrix and metabolism associated with myocardial infarction and heart failure.LKB1/Mo25/STRAD uniquely impacts sarcomeric contractile function and posttranslational modification.Muscle as a "mediator" of systemic metabolismAbnormalities of capillary microarchitecture in a rat model of coronary ischemic congestive heart failure.Revealing Pathway Dynamics in Heart Diseases by Analyzing Multiple Differential NetworksCardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure.Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice.c-Myc Alters Substrate Utilization and O-GlcNAc Protein Posttranslational Modifications without Altering Cardiac Function during Early Aortic ConstrictionThe ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination.Mechanical Stretch Inhibits MicroRNA499 via p53 to Regulate Calcineurin-A Expression in Rat CardiomyocytesMetabolomic approach to profile functional and metabolic changes in heart failure.Non-targeted metabolomics of Brg1/Brm double-mutant cardiomyocytes reveals a novel role for SWI/SNF complexes in metabolic homeostasis.Decline of Phosphotransfer and Substrate Supply Metabolic Circuits Hinders ATP Cycling in Aging Myocardium.Heart-Specific Knockout of the Mitochondrial Thioredoxin Reductase (Txnrd2) Induces Metabolic and Contractile Dysfunction in the Aging Myocardium.Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart FailureE2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated CardiomyopathyA mathematical model for active contraction in healthy and failing myocytes and left ventricles.Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy.The Potential of Metabolic Imaging.The Correlation of PPARα Activity and Cardiomyocyte Metabolism and Structure in Idiopathic Dilated Cardiomyopathy during Heart Failure Progression.Rapamycin transiently induces mitochondrial remodeling to reprogram energy metabolism in old hearts.Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.
P2860
Q26749206-BD3F8169-D4ED-454A-B76F-64A04AD875EFQ26776101-605113F3-2ABA-46B5-88B0-8CC5DFD5C0AFQ26822734-160CC13B-5FB5-45CE-88A9-44026447FEF0Q27001001-C2E3E54B-A7D4-4A1A-AADC-18BC64E4C08AQ28077186-03CF9EA6-A9C3-4680-8E8B-59E3FF28E977Q28118657-6C9B4A93-D68B-44D4-9B48-B0362AB6F15AQ28391449-94CD788B-6A60-4A59-BA84-3E2E66566985Q28395925-F6BEF37F-9C5D-4175-B2C0-D6171E5A8555Q30243930-37E922A5-4A35-4905-87F4-2935FD0EFB28Q30433369-769D4BE4-85DD-4E04-82DC-42B76ABD3804Q30620850-4C023B21-DF63-4E82-B097-487EFDB7DE4DQ30833466-440D2D35-01BE-4128-BDD1-CE4436E652E1Q31119881-BBDD7490-2DC6-4331-AFDF-734E60F7F311Q33758755-2F289DD8-0111-4706-AA8F-11D9DD20431CQ34039481-43C25210-6541-4CB5-8E18-43D577E3D014Q34628699-DF9109A7-29A0-4F1F-A17E-401E8D63E669Q34949313-1D44D521-625C-4DCB-9FAD-993E9FD3C59EQ35162103-3AFC33CF-0689-46BB-A683-86850CD9CA68Q35221451-EDFE5072-DE04-40FA-AA89-2824D217A9A8Q35429223-95F79056-F2AB-4E7D-AC3F-359D22F91D9AQ35437314-F8461673-5285-4E16-B217-073B0CB5FF06Q35666295-E3DC6673-F51A-4845-8C6C-5CB8B0701E42Q35685117-FEFC1E10-7D35-4060-9B29-580C7F279FF0Q35731767-38B819E5-77B6-472E-9EB5-4E447A96EA33Q35743572-DDB45A6E-0354-48D4-BE33-249502B500AAQ35911960-CA6A71AE-0E8B-4667-B9A8-8AFFFBF65F8EQ35918043-43C19A17-5968-4F79-804D-0F102DF56BB1Q36053950-F1E54917-154A-49D6-B591-986C43BBF437Q36071801-94369538-60AB-4828-BE81-400F6342D771Q36072760-B26E503F-FA4E-4D82-955F-58E44E14066BQ36168834-54B7C137-8812-4FF0-BEB4-391AF8B25EF7Q36171264-7AA143B7-300E-4C2A-9D10-7E67AC50D830Q36246354-2C1AD333-1B74-413F-9917-ED3A516E06F1Q36248883-1B3FC8AB-AEAF-4AF5-8A78-CDB0651D2032Q36346046-B26B66C5-D04D-4114-B698-D8620A68417CQ36380987-75CD4EC5-B623-4478-9FF4-CC80E97974E5Q36392626-93B8C65F-A5C5-4E3C-B097-F78AA24F6974Q36627766-9C3526FA-1B57-40C1-A6B9-9E4D2170CFC3Q36681450-04DBA1B9-3435-4DAA-BD56-EF4F64373F73Q36885497-352FED45-B3AD-4E40-9BE3-613B32817AC5
P2860
Cardiac metabolism in heart failure: implications beyond ATP production.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiac metabolism in heart failure: implications beyond ATP production.
@en
Cardiac metabolism in heart failure: implications beyond ATP production.
@nl
type
label
Cardiac metabolism in heart failure: implications beyond ATP production.
@en
Cardiac metabolism in heart failure: implications beyond ATP production.
@nl
prefLabel
Cardiac metabolism in heart failure: implications beyond ATP production.
@en
Cardiac metabolism in heart failure: implications beyond ATP production.
@nl
P2860
P1433
P1476
Cardiac metabolism in heart failure: implications beyond ATP production
@en
P2093
Torsten Doenst
P2860
P304
P356
10.1161/CIRCRESAHA.113.300376
P577
2013-08-01T00:00:00Z